FDA Adverse Event Malfunction Summary report: N

COBAS TAQSCREEN MPX TEST, V2.0 CE-IVD

MDR report key: 11701536 · Received April 21, 2021

Report

Report Number
2243471-2021-00892
Event Type
Malfunction
Date Received
April 21, 2021
Date of Event
March 23, 2021
Report Date
April 21, 2021
Manufacturer
ROCHE MOLECULAR SYSTEMS, INC.
Product Code
QHO
PMA / PMN Number
NA
Removal / Correction Number
NA
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

NO ISSUES WERE IDENTIFIED WITH KIT LOTS E18109, E16111, E15557, 336610 DURING THE COURSE OF THE INVESTIGATION. THE MATERIAL NUMBER FOR THE COBAS TAQSCREEN MPX TEST, V2.0 US-IVD: 05969484190. (B)(4)

Description of Event or Problem · 0

A CUSTOMER IN (B)(6) REPORTED THE POSSIBILITY OF A (B)(6) WITH THE COBAS TAQSCREEN MPX TEST, V2.0, WHICH WAS USED TO TEST DONATION(S) TRANSFUSED INTO A THALASSEMIC RECIPIENT. (B)(6). THE CUSTOMER DID NOT PROVIDE OTHER INFORMATION OR EVIDENCE THAT INDICATES THAT THE RECIPIENT'S (B)(6) IS RELATED TO THE PREVIOUSLY TESTED BLOOD DONATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
600204 COBAS TAQSCREEN MPX TEST, V2.0 CE-IVD HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV QHO ROCHE MOLECULAR SYSTEMS, INC. NA 336610

Patients

Seq Age Sex Outcome Treatment
1